Global Point of Care
Diagnostic testing has been an indispensable tool in the fight against the COVID-19 pandemic. Since the infectious period is limited to the first five to ten days of the infection, prompt results are needed to change behaviors to limit transmission. Laboratory testing has allowed high sensitivity for patients coming in but can sometimes have extended turn-around times. For many patients with milder symptoms, they may show up at physician offices and urgent care so point-of-care molecular tests may better satisfy that population. Meanwhile, routine serial antigen tests have allowed schools and businesses to get back to face-to-face meetings and travel to resume.
Sheldon Campbell MD, PhD, FCAP
Professor of Laboratory Medicine
Yale School of Medicine
Associate Chief of Pathology and Laboratory
VA Connecticut Healthcare System
Deborah L. Birx, MD
Senior Fellow
George W. Bush Institute
John Hackett
DVP Applied Research and Technology
Abbott
Healthcare professionals
A Leader in Rapid Point-of-Care Diagnostics.
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.